Statistics

Total Visits

Views
Tenofovir for the prophylaxis of HBV reactivation in anti-HBC-positive patients with hematologic malignancies treated with rituximab: Preliminary results of a randomized study (preblin study)49

Select a period of time:

Number of views in the range

Views
Tenofovir for the prophylaxis of HBV reactivation in anti-HBC-positive patients with hematologic malignancies treated with rituximab: Preliminary results of a randomized study (preblin study)7

Views

Views
November 20250
December 20251
January 20260
February 20260
March 20264
April 20261
May 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
Australia1
Brazil1
Nicaragua1
Sweden1
Uruguay1
 

Top cities views

Views
Borås1
Corinth1
Managua1
Montevideo1
Sydney1
Várzea da Palma1